• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激素替代疗法用于心血管疾病一级预防试验的经验教训。

Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease.

作者信息

Mohandas Bhavna, Mehta Jawahar L

机构信息

Division of Cardiovascular Medicine, Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.

出版信息

Curr Opin Cardiol. 2007 Sep;22(5):434-42. doi: 10.1097/HCO.0b013e328201cb7a.

DOI:10.1097/HCO.0b013e328201cb7a
PMID:17762545
Abstract

PURPOSE OF REVIEW

Coronary heart disease in women is a common cause of morbidity and mortality, particularly after menopause. It was thought that estrogen and progesterone protected women from coronary heart disease. The recommendations of the recent Women's Health Initiative, however, are that hormone replacement therapy should not be used for primary prevention of coronary heart disease in women. Here, we have made a comprehensive review of major studies and comment on the validity of this recommendation. We have also analyzed the importance of dietary modification in primary prevention. In addition, we have delineated the important predictors of cardiovascular disease in women from prior observational and clinical studies.

RECENT FINDINGS

Recent major studies, including the Women's Health Initiative (WHI) and Heart and Estrogen/Progestin Replacement Study (HERS), studied the role of hormone replacement therapy in protecting women from coronary heart disease. These studies showed no significant reduction in coronary heart disease events. In addition, the dietary modification component of the Women's Health Initiative did not show any significant reduction in the incidence of coronary heart disease.

SUMMARY

It can be summarized that hormone replacement is not generally recommended in postmenopausal women for primary prevention of coronary heart disease. Although the dietary modification trials did not show any significant reduction in the incidence of coronary heart disease, it is currently recommended to continue using a heart-healthy diet.

摘要

综述目的

女性冠心病是发病和死亡的常见原因,尤其是在绝经后。过去认为雌激素和孕激素可保护女性免受冠心病困扰。然而,近期妇女健康倡议(Women's Health Initiative)的建议是,激素替代疗法不应被用于女性冠心病的一级预防。在此,我们对主要研究进行了全面综述,并对该建议的有效性进行了评论。我们还分析了饮食调整在一级预防中的重要性。此外,我们从既往观察性和临床研究中梳理出了女性心血管疾病的重要预测因素。

最新发现

近期的主要研究,包括妇女健康倡议(WHI)和心脏与雌激素/孕激素替代研究(HERS),探讨了激素替代疗法在保护女性免受冠心病困扰方面的作用。这些研究表明冠心病事件并未显著减少。此外,妇女健康倡议中的饮食调整部分也未显示冠心病发病率有任何显著降低。

总结

可以总结出,一般不建议绝经后女性使用激素替代疗法进行冠心病的一级预防。尽管饮食调整试验未显示冠心病发病率有任何显著降低,但目前仍建议继续采用有益心脏健康的饮食。

相似文献

1
Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease.激素替代疗法用于心血管疾病一级预防试验的经验教训。
Curr Opin Cardiol. 2007 Sep;22(5):434-42. doi: 10.1097/HCO.0b013e328201cb7a.
2
Comparative cardiovascular effects of different progestins in menopause.不同孕激素在绝经后对心血管系统的比较影响
Int J Fertil Womens Med. 2001 Sep-Oct;46(5):248-56.
3
Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI.德国绝经后女性人群中激素替代疗法的模式。HERS II和WHI之后的变化。
Exp Clin Endocrinol Diabetes. 2005 Oct;113(9):529-33. doi: 10.1055/s-2005-865802.
4
Postmenopausal hormones and coronary artery disease: potential benefits and risks.绝经后激素与冠状动脉疾病:潜在益处与风险
Climacteric. 2007 Oct;10 Suppl 2:21-6. doi: 10.1080/13697130701578631.
5
Heart disease in women.女性心脏病
Int J Fertil Womens Med. 2000 Nov-Dec;45(6):350-7.
6
KEEPS: The Kronos Early Estrogen Prevention Study.KEEPS:克罗诺斯早期雌激素预防研究。
Climacteric. 2005 Mar;8(1):3-12. doi: 10.1080/13697130500042417.
7
Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.特邀评论:激素治疗的风险与益处——妇女健康倡议研究结果及绝经后雌激素时机假说
Am J Epidemiol. 2009 Jul 1;170(1):24-8. doi: 10.1093/aje/kwp113. Epub 2009 May 25.
8
[Prevention of coronary heart disease by early postmenopausal hormone therapy: new supporting data].绝经后早期激素治疗预防冠心病:新的支持数据
J Gynecol Obstet Biol Reprod (Paris). 2008 Jun;37(4):340-5. doi: 10.1016/j.jgyn.2007.12.003. Epub 2008 Feb 4.
9
Where are we with postmenopausal hormone therapy in 2005?2005年我们在绝经后激素治疗方面处于什么状况?
Gynecol Endocrinol. 2005 Nov;21(5):248-56. doi: 10.1080/09513590500279733.
10
Hormone therapy for younger postmenopausal women: how can we make sense out of the evidence?年轻绝经后女性的激素治疗:我们如何理解这些证据?
Climacteric. 2005 Dec;8(4):307-10. doi: 10.1080/13697130500345505.

引用本文的文献

1
Activation of G protein-coupled estrogen receptor induces endothelium-independent relaxation of coronary artery smooth muscle.G 蛋白偶联雌激素受体的激活可诱导冠状动脉平滑肌产生非内皮依赖性舒张反应。
Am J Physiol Endocrinol Metab. 2011 Nov;301(5):E882-8. doi: 10.1152/ajpendo.00037.2011. Epub 2011 Jul 26.
2
An association between gene expression and better survival in female mice following myocardial infarction.心肌梗死后雌性小鼠的基因表达与更好的生存之间存在关联。
J Mol Cell Cardiol. 2010 Nov;49(5):801-11. doi: 10.1016/j.yjmcc.2010.08.002. Epub 2010 Aug 6.